Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Metastatic Melanoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-08-1002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Phase I Study of 17-Allylamino-17 Demethoxygeldanamycin, Gemcitabine and/or Cisplatin in Patients With Refractory Solid Tumors

Investigational New Drugs
OncologyPharmacology
2010English

Phase I Pharmacokinetic-Pharmacodynamic Study of 17-(Allylamino)-17-Demethoxygeldanamycin (17AAG, NSC 330507), a Novel Inhibitor of Heat Shock Protein 90, in Patients With Refractory Advanced Cancers

Clinical Cancer Research
Cancer ResearchOncology
2005English

Sulforaphane Potentiates the Efficacy of 17-Allylamino 17-Demethoxygeldanamycin Against Pancreatic Cancer Through Enhanced Abrogation of Hsp90 Chaperone Function

Nutrition and Cancer
MedicineNutritionOncologyCancer ResearchDietetics
2011English

17-Allylamino-17-Demethoxygeldanamycin Down-Regulates Hyaluronic Acid-Induced Glioma Invasion by Blocking Matrix Metalloproteinase-9 Secretion

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2008English

The Hsp90 Inhibitor 17-(Allylamino)-17-Demethoxygeldanamycin Increases Cisplatin Antitumor Activity by Inducing P53-Mediated Apoptosis in Head and Neck Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2013English

Enhanced Recovery From Contraction-Induced Damage in Skeletal Muscles of Old Mice Following Treatment With the Heat Shock Protein Inducer 17-(Allylamino)-17-Demethoxygeldanamycin

Rejuvenation Research
AgingGerontologyGeriatrics
2008English

Cooperative Enhancement of Radiosensitivity After Combined Treatment of 17-(Allylamino)-17-Demethoxygeldanamycin and Celecoxib in Human Lung and Colon Cancer Cell Lines

DNA and Cell Biology
MedicineGeneticsCell BiologyMolecular Biology
2012English

A Phase II, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Gene Regulatory and Clinical Effects of Interferon Β in Patients With Metastatic Melanoma: A Phase II Trial

Journal of Interferon and Cytokine Research
MedicineVirologyImmunologyCell Biology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy